Topic
Andexxa
2 published works
Drug Injury Watch
Andexxa Drug Recall December 2025 Due In Part To Safety Issue That Involves Blood Clots
By Tom Lamb
High Rate Of Thrombotic Events And More Thrombosis-related Deaths Compared To Standard Antidote Treatment (Posted by Tom Lamb at Drug Injury Watch) Just about a year ago, we wrote about the possibility of…
Drug Injury Watch
Do Andexxa Risks Outweigh Benefits Given Increased Rate of Thrombosis and Thrombosis-Related Deaths?
By Tom Lamb
Issue to be Considered by FDA Advisory Committee on November 21, 2024, and Discussion May Lead to Andexxa Drug Recall (Posted by Tom Lamb at Drug Injury Watch) At its November…